
Antioxidants, Journal Year: 2025, Volume and Issue: 14(5), P. 548 - 548
Published: May 1, 2025
(1) Background: Rheumatoid arthritis (RA) is a chronic inflammatory condition known for its symptoms of joint damage and cartilage breakdown. Current treatments frequently result in adverse effects show restricted efficacy the long term. Dendropanax morbiferus, plant recognized bioactive properties, demonstrates promise treatment conditions. The objective this study was to examine therapeutic properties morbiferus Lév. water extract (DMWE) RA through utilization vitro vivo models. (2) Methods: Ultra-high-performance liquid chromatography (UPLC) analysis used identify compounds DMWE. Antioxidant activity evaluated using 1,1-diphenyl-2-picrylhydrazyl (DPPH) 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical-scavenging assays. experiments involved CHON-001 cells with DMWE order assess impacts on inflammation matrix metalloproteinase (MMP) expression. impact Janus Kinase 2 (JAK2) Signal Transducer Activator Transcription (STAT) signaling pathways also assessed. induced Balb/c mice who were subsequently treated varying doses morphology, edema, body weight. (3) Results: demonstrated substantial antioxidant hindered expression MMP-2 MMP-8 chondrocytes IL-1β. It additionally inhibited JAK2/STAT pathway diminished responses. Treatment living organisms led decrease swelling, improved weight regains, maintained structure, higher exhibiting similar those positive control, dexamethasone (Dexa). (4) Conclusions: found have excellent anti-inflammatory activities. In an RA-induced mouse model, DMWE-3 (500 mg/kg BW) effectively treat by reducing concentration pro-inflammatory factors preventing deformation.
Language: Английский